TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.

Frank A Sinicrope et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.